Skip to main content

CCTG Connection



Published:
Category: Publications
Publication: Hematology guidence and MA21 substudy
Two publications - one for Hematology guidance for measurable/minimal residual disease (MRD) and a Ma21 sub-study around insomnia and how it affects the immune system. Read More

Published:
Category: Publications
HE1 awarded 2024 Till and McCulloch Paper of the year
The HE1 paper published in The Lancet Oncology won the "2024 Princess Margaret Cancer Centre Till and McCulloch Paper of the year (Clinical)" award recognizing outstanding clinical research in the field of oncology, led by a researcher at Princess Margaret Cancer Centre. The Till & McCulloch Award is in honour of Canadian scientists James Till and Ernest McCulloch, whose pioneering work established the field of stem cell research. Read More

Published:
Category: Publications
The CO21 CHALLENGE trial results

In a world-first clinical trial, researchers working with the Canadian Cancer Trials Group (CCTG) have demonstrated that a structured exercise program significantly improves survival for colon cancer patients by reducing the risk of disease recurrence and new primary cancers.

Read More

Published:
Category: Publications
CCTG MA.40 FINER clinical trial

The CCTG MA.40 (FINER) clinical trial, is a double-blind placebo controlled randomized phase III trial of fulvestrant and ipatasertib as treatment for advanced HER-2 negative and estrogen receptor positive (ER+) breast cancer following progression on first line CDK 4/6 inhibitor and aromatase inhibitor.

Read More



Published:
Category: Group updates
2026 CCTG Annual Spring Meeting of Participants
Don't forget to mark your calendars and save the date for the next CCTG Spring Meeting which will be Friday, April 24 – Sunday, April 26, 2026 at the Chelsea Hotel in Toronto. Read More

Published:
Category: Group updates
CCTG is looking for two Health Equity Leads
CCTG is seeking interested individuals with a background in health equity to serve as Health Equity Leads. Please submit the application form with a CV by May 30, 2025. Read More

Published:
Category: Group updates
CCTG at 2025 ASCO Annual Meeting

The ASCO 2025 Annual Meeting, is fast approaching and will be held from May 30 to June 3 in Chicago, Illinois -- This year the theme is of "Driving Knowledge to Action: Building a Better Future". This meeting will feature many CCTG trials and research so please see the list below to ensure you do not miss the oral presentations or poster presentations, showcasing the latest in CCTG research and clinical trial results.

 

Read More

Published:
Category: News
Call for Applications: Fall 2025 CIHR-ICR Early Career Researcher Workshop

The CIHR Early Career Researcher Workshop

As part of the CIHR commitment to promote capacity building in the Canadian cancer research landscape, the CIHR Institute of Cancer Research (CIHR-ICR), in partnership with the Canadian Cancer Research Alliance (CCRA), Canadian Cancer Society (CCS), Cancer Research Society (CRS), Ontario Institute for Cancer Research (OICR), and Terry Fox Research Institute (TFRI), has announced the open call for applications for its Early Career Researcher (ECR) Workshop.

Read More